Valvular calcification is a key step in the progression of advanced CAVD and has been associated with local and systemic derangements in the OPG/RANK/RANKL bone metabolism regulatory pathway. The gene discussed is TNFRSF11A; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.